Cargando…

The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using (18)F-AV45: Is Amyloid the Principal Actor in the Disease?

BACKGROUND: Posterior cortical atrophy (PCA) is characterized by progressive higher-order visuoperceptual dysfunction and praxis declines. This syndrome is related to a number of underlying diseases, including, in most cases, Alzheimer's disease (AD). The aim of this study was to compare the am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beaufils, Emilie, Ribeiro, Maria Joao, Vierron, Emilie, Vercouillie, Johnny, Dufour-Rainfray, Diane, Cottier, Jean-Philippe, Camus, Vincent, Mondon, Karl, Guilloteau, Denis, Hommet, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2014
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264487/ https://www.ncbi.nlm.nih.gov/pubmed/25538727 http://dx.doi.org/10.1159/000363761

Ejemplares similares

Using PET with (18)F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
por: Camus, V., et al.
Publicado: (2012)

Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer
por: Bailly, Matthieu, et al.
Publicado: (2015)

Idiopathic Parkinson’s disease phenotype related to C9ORF72 repeat expansions: contribution of the neuropsychological assessment
por: Annan, Mariam, et al.
Publicado: (2013)

Could (18) F-DPA-714 PET imaging be interesting to use in the early post-stroke period?
por: Ribeiro, Maria-Joao, et al.
Publicado: (2014)

Usefulness of PET With [(18)F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment
por: Ribeiro, Maria-Joao, et al.
Publicado: (2020)

Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort
por: Li, Jin, et al.
Publicado: (2015)

Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [(18)F]AV-45 Positron Emission Tomography in Chinese Population
por: Huang, Kuo-Lun, et al.
Publicado: (2013)

Targeting Amyloids with [(18)F]AV-45 for Medullary Thyroid Carcinoma Positron Emission Tomography/Computed Tomography Imaging: A Pilot Clinical Study
por: Li, Chun, et al.
Publicado: (2022)

Design effect in multicenter studies: gain or loss of power?
por: Vierron, Emilie, et al.
Publicado: (2009)

AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2016)

Airway hyperresponsiveness; smooth muscle as the principal actor
por: Lauzon, Anne-Marie, et al.
Publicado: (2016)

Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease
por: Therriault, Joseph, et al.
Publicado: (2021)

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
por: Singh, Tarun D., et al.
Publicado: (2015)

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
por: Insel, Philip S., et al.
Publicado: (2017)

Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451
por: Firouzian, Azadeh, et al.
Publicado: (2018)

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease
por: Kerbler, Georg M, et al.
Publicado: (2014)

Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: An ALS mimicker
por: Goyal, Namita A., et al.
Publicado: (2015)

Longitudinal trajectory of Amyloid‐related hippocampal subfield atrophy in nondemented elderly
por: Zhang, Liwen, et al.
Publicado: (2020)

Bile Acids in Dementia: Brain Amyloid, White Matter Lesions, and Atrophy
por: Varma, Vijay, et al.
Publicado: (2020)

Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021)

Familial Alzheimer’s disease mutations in amyloid protein precursor alter proteolysis by γ-secretase to increase amyloid β-peptides of ≥45 residues
por: Devkota, Sujan, et al.
Publicado: (2021)

Cerebral Amyloid Angiopathy-Related Inflammation following Multiple Cancers and Chemotherapies
por: Severijns, Christophe, et al.
Publicado: (2022)

Optimization of Automatic Synthesis and Separation of [(18)F] AV-45 and Quality Control
por: Zhang, Qi-Zhou, et al.
Publicado: (2022)

Association of angiitis of central nervous system, cerebral amyloid angiopathy, and Alzheimer’s disease: Report of an autopsy case
por: Annweiler, Cédric, et al.
Publicado: (2008)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
por: Svenningsson, Anna Linnéa, et al.
Publicado: (2022)

The amyloid precursor protein: beyond amyloid
por: Zheng, Hui, et al.
Publicado: (2006)

Detection of Neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [(18)F]DPA-714 PET Imaging
por: Thomas, Clément, et al.
Publicado: (2016)

Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography
por: Li, Yuan, et al.
Publicado: (2019)

Amyloid β-Sheet Mimics that Antagonize Amyloid Aggregation and Reduce Amyloid Toxicity
por: Cheng, Pin-Nan, et al.
Publicado: (2012)

AV monografías = AV monographs.
Publicado: (1995)

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2017)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
por: ten Kate, Mara, et al.
Publicado: (2017)

Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy
por: Putcha, Deepti, et al.
Publicado: (2019)

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
por: Abdelnour, Carla, et al.
Publicado: (2020)

Small vessel disease lesion type and brain atrophy: The role of co‐occurring amyloid
por: Heinen, Rutger, et al.
Publicado: (2020)

Serum amyloid A1 mediates myotube atrophy via Toll‐like receptors
por: Hahn, Alexander, et al.
Publicado: (2019)

Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
por: Pereira, Joana B, et al.
Publicado: (2021)

Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort
por: Loreto, Flavia, et al.
Publicado: (2023)

Good Amyloid, Bad Amyloid—What’s the Difference?
por: Roberts, Roland G.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v6ff7dk2fib0q11db6t1cgdpcm